Stopped
Ketamine in Severe Traumatic Brain Injury
Trial status changed: Recruiting → Withdrawn
University of Texas Southwestern Medical CenterEarly Phase 1 NCT06062628 Registry history of NCT06062628 on ClinicalTrials.gov (opens the registry)
15 trials changed in the last 30 days: 2 stopped, 9 with notable changes, 4 with minor changes only.
Trial status changed: Recruiting → Withdrawn
University of Texas Southwestern Medical CenterEarly Phase 1 NCT06062628 Registry history of NCT06062628 on ClinicalTrials.gov (opens the registry)
Recruitment suspended
University of Texas Southwestern Medical CenterNot specified NCT04232631 Registry history of NCT04232631 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Dec 31, 2026 to Apr 30, 2029
Also in this update: Study completion pushed from Jun 30, 2027 to Oct 31, 2029
University of Texas Southwestern Medical CenterNot specified NCT06398158 Registry history of NCT06398158 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Nov 30, 2026 to Nov 30, 2027
Also in this update: Study completion pushed from May 31, 2027 to May 31, 2028
University of Texas Southwestern Medical CenterEarly Phase 1 NCT05594017 Registry history of NCT05594017 on ClinicalTrials.gov (opens the registry)
Primary completion pushed from Aug 2026 to Jul 2027
University of Texas Southwestern Medical CenterPhase 1 NCT07100847 Registry history of NCT07100847 on ClinicalTrials.gov (opens the registry)
Primary endpoint(s) modified
Also in this update: Phase changed: not specified → not applicable; Sponsor changed: [Redacted] to University of Texas Southwestern Medical Center
University of Texas Southwestern Medical CenterNot applicable NCT06866353 Registry history of NCT06866353 on ClinicalTrials.gov (opens the registry)
Recruitment opened
University of Texas Southwestern Medical CenterNot applicable NCT07350551 Registry history of NCT07350551 on ClinicalTrials.gov (opens the registry)
Recruitment opened
University of Texas Southwestern Medical CenterNot specified NCT07692217 Registry history of NCT07692217 on ClinicalTrials.gov (opens the registry)
Recruitment opened
University of Texas Southwestern Medical CenterNot specified NCT07430774 Registry history of NCT07430774 on ClinicalTrials.gov (opens the registry)
Results posted: Oct 7, 2026
University of Texas Southwestern Medical CenterPhase 4 NCT06481150 Registry history of NCT06481150 on ClinicalTrials.gov (opens the registry)
Results posted: Oct 7, 2026
Also in this update: Final enrollment: 105 participants (planned 135)
University of Texas Southwestern Medical CenterNot applicable NCT02645487 Registry history of NCT02645487 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Mar 31, 2031 to Dec 2, 2024
University of Texas Southwestern Medical CenterNot specified NCT02791880 Registry history of NCT02791880 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Final enrollment: 35 participants (planned 45); Primary completion date changed from estimate of Mar 31, 2026 to Feb 12, 2026
University of Texas Southwestern Medical CenterPhase 2 NCT06745128 Registry history of NCT06745128 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jul 31, 2026 to Feb 1, 2026
University of Texas Southwestern Medical CenterPhase 2 NCT05886816 Registry history of NCT05886816 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Oct 2031 to Dec 2031
Also in this update: Interventions modified
University of Texas Southwestern Medical CenterEarly Phase 1 NCT07228338 Registry history of NCT07228338 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-16 | NCT07878689 Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma | Phase 1/2 | Not Yet Recruiting |
| 2026-10-05 | NCT07857057 Food Introduction for Risk Reduction, Support Tolerance: Behavioral Intervention for… | Not Yet Recruiting | |
| 2026-09-30 | NCT07849920 Walk Together Efficacy Trial | Not Yet Recruiting |
| Early Phase 1 | 10 | |
| Phase 1 | 14 | |
| Phase 1/2 | 12 | |
| Phase 2 | 34 | |
| Phase 2/3 | 2 | |
| Phase 3 | 6 | |
| Phase 4 | 10 |
Heart Disease (20) · Depression (14) · Heart Failure (11) · Obesity (10) · Breast Cancer (9) · Liver Cancer (9) · Lung Cancer (9) · Prostate Cancer (9) · Diabetes (8) · Hypertension (8)